Evidence map›Paper›PMID 34198760›Full record

ArticleCancers2021

Prognostic Value of Tie2-Expressing Monocytes in Chronic Lymphocytic Leukemia Patients.

Justyna Woś, Sylwia Chocholska, Wioleta Kowalska, Waldemar Tomczak, Agata Szymańska, Agnieszka Karczmarczyk, Agnieszka Szuster-Ciesielska, Agnieszka Wojciechowska, Agnieszka Bojarska-Junak

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Prognostic Value of the miR-17~92 Cluster in Chronic Lymphocytic Leukemia.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Justyna WośChair and Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland.
Sylwia ChocholskaDepartment of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20-080 Lublin, Poland.
Wioleta KowalskaChair and Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0003-0930-5874
Waldemar TomczakDepartment of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20-080 Lublin, Poland.
Agata SzymańskaDepartment of Clinical Transplantology, Medical University of Lublin, 20-093 Lublin, Poland.
Agnieszka KarczmarczykDepartment of Experimental Hematooncology, Medical University of Lublin, 20-093 Lublin, Poland.
Agnieszka Szuster-CiesielskaDepartment of Virology and Immunology, Institute of Biological Sciences, Maria Curie-Skłodowska University, 20-033 Lublin, Poland.
Agnieszka WojciechowskaFaculty of Chemistry, Wroclaw University of Science and Technology, 50-370 Wrocław, Poland.ORCID 0000-0002-0854-7882
Agnieszka Bojarska-JunakChair and Department of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0003-2340-9442
Medical University of Lublin · PLMaria Curie-Skłodowska University · PLWrocław University of Science and Technology · PL

Funding

Uniwersytet Medyczny w Lublinie Ds 458
6 · The paper itself

Abstract

Tie2-expressing monocytes (TEMs) are associated with tumor progression and metastasis. This unique subset of monocytes has been identified as a potential prognostic marker in several solid tumors. However, TEMs remain poorly characterized in hematological cancers, including chronic lymphocytic leukemia (CLL). This study analyzed, for the first time, the clinical significance of TEM population in CLL patients. Flow cytometry analysis of TEMs (defined as CD14

Indexed as

CLLmonocytesTEMTie2

Identifiers

PMID34198760
PMCPMC8200999
OpenAlexW3171059344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.